Celldex Therapeutics, Inc. (CLDX)
28.25
-1.68
(-5.61%)
USD |
NASDAQ |
Nov 05, 16:00
27.87
-0.38
(-1.35%)
After-Hours: 19:32
Celldex Therapeutics Price to Book Value : 3.103 for Nov. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2026 | 3.288 |
| November 03, 2026 | 3.264 |
| November 02, 2026 | 3.190 |
| October 30, 2026 | 3.307 |
| October 29, 2026 | 3.284 |
| October 28, 2026 | 3.258 |
| October 27, 2026 | 3.312 |
| October 26, 2026 | 3.241 |
| October 23, 2026 | 3.213 |
| October 22, 2026 | 3.183 |
| October 21, 2026 | 3.226 |
| October 20, 2026 | 3.328 |
| October 19, 2026 | 3.260 |
| October 16, 2026 | 3.024 |
| October 15, 2026 | 3.178 |
| October 14, 2026 | 3.058 |
| October 13, 2026 | 3.104 |
| October 12, 2026 | 3.233 |
| October 09, 2026 | 3.284 |
| October 08, 2026 | 3.219 |
| October 07, 2026 | 3.343 |
| October 06, 2026 | 3.406 |
| October 05, 2026 | 3.580 |
| October 02, 2026 | 3.477 |
| October 01, 2026 | 3.535 |
| Date | Value |
|---|---|
| September 30, 2026 | 3.560 |
| September 29, 2026 | 3.476 |
| September 28, 2026 | 3.459 |
| September 25, 2026 | 3.417 |
| September 24, 2026 | 3.458 |
| September 23, 2026 | 3.419 |
| September 22, 2026 | 3.681 |
| September 21, 2026 | 4.162 |
| September 18, 2026 | 4.201 |
| September 17, 2026 | 4.282 |
| September 16, 2026 | 4.253 |
| September 15, 2026 | 4.231 |
| September 14, 2026 | 4.304 |
| September 11, 2026 | 4.054 |
| September 10, 2026 | 4.186 |
| September 09, 2026 | 4.260 |
| September 08, 2026 | 4.298 |
| September 04, 2026 | 4.359 |
| September 03, 2026 | 4.325 |
| September 02, 2026 | 4.337 |
| September 01, 2026 | 4.311 |
| August 31, 2026 | 4.354 |
| August 28, 2026 | 4.298 |
| August 27, 2026 | 4.445 |
| August 26, 2026 | 4.457 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.796 |
| Alnylam Pharmaceuticals, Inc. | 5.813 |
| Anika Therapeutics, Inc. | 1.881 |
| Savara, Inc. | 6.262 |
| Vericel Corp. | 7.141 |
Price to Book Value Related Metrics
| PS Ratio | 12395.80 |
| PEG Ratio | -0.1443 |
| Price | 28.25 |
| Earnings Yield | -15.43% |
| Market Cap | 2.218B |
| PEGY Ratio | -0.1443 |